Neuromation Won a Prize on d10e in Gibraltar
MALAGA, Spain (PRWEB) November 09, 2017 -- Neuromation is a platform that helps to meet datasets, computer power and machine learning models.
It's Neuromation's second win at the d10e international conference, which was held in September in Kiev, Ukraine. Following this, David Orban, an investor, entrepreneur, author and thought leader of the global technology landscape, as well as a member of faculty of the Singularity University, became advisor to Neuromation.io.
d10e has been the leading conference on decentralization since 2014. Past editions were hosted in Amsterdam, Bucharest, Kyiv, San Francisco, Singapore and Tel Aviv. The main focus was to explore the Future of FinTech, ICOs, Blockchain, Sharing Economy, Future of Work & Disruptive Culture.
The Neuromation Platform will use distributed computing along with blockchain proof of work tokens to revolutionize AI model development. Neuromation is a technology platform that creates synthetic learning environments for deep learning of neural networks. These simulations are then used for training better algorithms.
We are building a platform of distributed computing for creating artificial worlds where AI algorithms are trained on simulated sensory input. These synthetic worlds also have a virtually infinite supply of perfectly labeled training data. AI plays, as with video games, in order to learn specific real-world tasks.
_________________________________________________________
More about Neuromation: https://neuromation.io/
Headquarters: San Francisco, CA
Year founded: 2016
Video of Neuromation: https://www.youtube.com/watch?v=zHcBA89xq3w&t=13s
Join Neurotoken sale https://ico.neuromation.io/en/
Neuromation is the first client of it’s own distributed computing network. We have developed “Neuromation Labs” that create synthetic data and train deep learning models on live applications.
Retail Lab
In our retail lab we have partnered with OSA HP (http://osahp.com/en/) and ECR (http://ecr-all.org/?lang=en) to supply 170,000 item synthetic retail data set for Eastern Europe. The contract potential is over 4.25M Euro over 18 months time frame. Here is an example of the model deployment on a mobile device: https://youtu.be/QO1KGwQKoSU
Medical Devices Lab
In our medical devices lab we have partnered with MonBaby (https://monbaby.com/), a leading infant tracking technology provider, to create a smart camera to augment their existing offering. The camera will be tracking motion of the child and giving their caretakers valuable analytics. Neuromation will be receiving a revenue share from each sold device. Revenue potential is 2M+ euros over the next few years.
The Neurotoken pre-sale was launched on October, 25th, https://ico.neuromation.io/en/, just after the announcement of the partnership with Hacken, aimed at auditing and improving the security of the code and cloud infrastructure.In addition to this, TaaS fund also partnered with Neuromation. Tokens issued during the pre-ICO phase will be offered with a 25 per cent bonus in Neurotokens for investors who register through the whitelist.
The Token sale will be held on November 28, 2017 – January 1, 2018. The total amount of placement is 60,000,000 Neurotokens, with a capital target of around $17M. No additional tokens will be issued afterwards, and all unsold tokens will be burned.
https://t.me/neurotoken_io
https://www.fb.com/neuromation/
Anastasia, Neuromation, http://Neuromation.io, +7 9859232184, [email protected]
Share this article